Investigating the role of neurogranin in traumatic brain injury

Neurogranin and Traumatic Brain Injury

NIH-funded research Veterans Health Administration · NIH-10948917

This study is looking at a protein called neurogranin to see how it might affect thinking problems after a traumatic brain injury, especially in military personnel, and aims to find new ways to help improve brain function for those dealing with these challenges.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Pittsburgh, United States)
Project IDNIH-10948917 on NIH RePORTER

What this research studies

This research focuses on understanding how neurogranin, a protein involved in synaptic function, may play a role in the cognitive impairments associated with traumatic brain injury (TBI), particularly in military personnel. The study aims to explore the cellular mechanisms underlying TBI-related cognitive deficits using animal models that mimic the effects of TBI. By examining synaptic strength and plasticity, the research seeks to identify potential therapeutic targets that could lead to new treatments for TBI. The ultimate goal is to develop pharmacotherapies that can improve cognitive function in individuals suffering from the long-term effects of TBI.

Who could benefit from this research

Good fit: Ideal candidates for this research include military personnel who have experienced traumatic brain injuries, particularly those with persistent cognitive impairments.

Not a fit: Patients who have not experienced traumatic brain injuries or those with cognitive impairments due to other causes may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve cognitive function and quality of life for individuals affected by traumatic brain injury.

How similar studies have performed: Previous research has shown promise in using animal models to investigate cognitive impairments related to TBI, indicating that this approach may yield valuable insights.

Where this research is happening

Pittsburgh, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.